Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC).

Authors

null

Erwin Woff

Nuclear Medicine Department, Institut Jules Bordet - Université Libre de Bruxelles (ULB), Brussels, Belgium

Erwin Woff , Pashalina Kehagias , Caroline Vandeputte , Tarek Kamoun , Thomas Guiot , Lieveke Ameye , Karen Paula Geboes , Thierry Delaunoit , Gauthier Demolin , Marc Peeters , Lionel A. D'Hondt , Jos Janssens , Javier Carrasco , Stephane Holbrechts , Jean-Charles Goeminne , Jean-Luc Van Laethem , Philippe Vergauwe , Marianne Paesmans , Alain Hendlisz , Patrick Flamen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

Molecular Diagnostics and Imaging

Clinical Trial Registration Number

2012-005655-16

Citation

J Clin Oncol 35, 2017 (suppl; abstr 11569)

DOI

10.1200/JCO.2017.35.15_suppl.11569

Abstract #

11569

Poster Bd #

269

Abstract Disclosures

Similar Posters

Poster

2019 Gastrointestinal Cancers Symposium

On-treatment changes of plasma protein biomarkers in CALGB/SWOG 80405 (Alliance).

On-treatment changes of plasma protein biomarkers in CALGB/SWOG 80405 (Alliance).

First Author: Ace Joseph Hatch

First Author: Erin Fidyk

First Author: Rongrong Li